Videos

Shared insight on how disruption of the gut microbiome may occur based on antibiotic exposure, environmental factors, and diet.

Expert panelists review the pathophysiology of marginal zone lymphoma and reflect on its prevalence as a rare disease.

Opening their discussion on Clostridioides difficile, experts provide an overview on the gut microbiome and colonization resistance.

Social determinants of health can play a significant role in the treatment trajectory and outcomes for patients with cancer because oncology care requires close communication between the patient and clinicians.

Kristen Demundo, PharmD, and Shannon M. Rotolo, PharmD, BCPS, review the important role pharmacists play in helping patients manage their atopic dermatitis condition and treatment.

A panel of experts discuss JAK inhibitors and their potential impact on the management of atopic dermatitis.

Pharmacy Times spoke to Michael Young, MBA, Vice President of Pharmacy Strategy, Parata Systems, about centralization and automation in the pharmacy field and how these tools can create new solutions for pharmacists.

Panel of experts discuss the increasing roles and responsibilities in the pharmacy technician space as integral members of the pharmacy patient care team.

Pharmacists should keep an eye on the pipeline for autologous and allogeneic CAR T-cell therapies as well as antibody-specific treatments.

Joanna Lewis, PharmD, MBA, highlights data from Pharmacy Times®’ OTC Guide and discusses practical information on the selection of sunscreen to prevent skin damage and cancer.

Hizentra is indicated for the treatment of primary immunodeficiency in adults and pediatric patients 2 years of age and older and maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy.

With so many approved regimens and common use of oral agents in the treatment of multiple myeloma, oncology pharmacists are essential team members.

Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, discusses the implications of research into the treatment of liver metastases in patients with gastrointestinal NETs.

Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses the role setting has in the care of patients with Burkitt lymphoma.

Kyle Detwiler, CEO of Clever Leaves, discusses his company’s donation of $1 million in medical-grade cannabis to research organizations for the purposes of advancing medical research.

Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, discusses the findings regarding the efficacy of combining and sequencing liver-directed therapy with systemic therapy.

Ismail Lourido Ali, the director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), addresses the difference between legalization and decriminalization of psychedelic drugs, specifically in reference to the impact on medical research.

Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, discusses areas of concern when approaching the combination and sequencing of liver-directed therapy with systemic therapy.

Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses how the care setting can impact patient outcomes in the treatment of Burkitt lymphoma.

Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, discusses the potential sequencing in the combination of liver-directed therapy with systemic therapy.

Bhavesh Shah, RPh, BCOP; and Thomasina Morris, RPh, MHA, BCOP, delve into the challenges faced with using PARP inhibitors as second-line maintenance therapy for the treatment of ovarian cancer.

Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, discusses the results of combining liver-directed therapy with systemic therapy when treating patients with gastrointestinal neuroendocrine tumors.

Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, discussed how systemic therapy differs from liver-directed therapy.

Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses the rate of treatment-related mortality and the most common causes in the treatment of Burkitt lymphoma.

Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, discussed how liver-directed therapy is approached in the treatment of liver metastases in patients with gastrointestinal neuroendocrine tumors.

Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses what pharmacists can do to support patients in the intervention or prevention of chronic kidney disease.

Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses the role of Nrf2 and vitamin K in DNA damage signaling, senescence, and inflammaging.

Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses the link between senescence and early vascular aging in the context of chronic kidney disease.

Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses what may be some of the contributing factors to early vascular aging and how might they be counteracted.

Jennifer Andrews, MD, pediatric hematologist-oncologist at Vanderbilt University Medical Center and medical director of Vanderbilt University Medical Center’s blood bank, discusses what health systems can do to address the national blood shortage and increase blood donations.